Gavin Cull

Dr

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 84 Citations
  • 5 h-Index
19962019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gavin Cull is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Fibroblast Growth Factor 7 Medicine & Life Sciences
T-Cell Leukemia Medicine & Life Sciences
Nomograms Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Polyphenols Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 84 Citations
  • 5 h-Index
  • 13 Article
  • 3 Letter
1 Citation (Scopus)

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement

Chin, C. K., Tsang, E., Mediwake, H., Khair, W., Biccler, J., Hapgood, G., Mollee, P., Nizich, Z., Joske, D., Radeski, D., Cull, G., Villa, D., El-Galaly, T. C. & Cheah, C. Y., 1 Mar 2019, In : British Journal of Haematology. 184, 5, p. 826-828 3 p.

Research output: Contribution to journalLetter

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Tam, C. S., Trotman, J., Opat, S., Burger, J. A., Cull, G., Gottlieb, D., Harrup, R., Johnston, P. B., Marlton, P., Munoz, J., Seymour, J. F., Simpson, D., Tedeschi, A., Elstrom, R., Yu, Y., Tang, Z., Han, L., Huang, J., Novotny, W., Wang, L. & 1 othersRoberts, A. W., 12 Sep 2019, In : Blood. 134, 11, p. 851-859 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Toxicity
B-Lymphocytes
Cells
Safety

Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western Australia

Kuzich, J. A., Hutchison, A. P., Lim, K. J. C., Smallbone, P., Denning, K., Wright, M. P., Cull, G., Leah, M. F., Joske, D. J. L., Radeski, D. & Purtill, D., Jul 2019, In : LEUKEMIA & LYMPHOMA. 9 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

Bromberg, J. E. C., Issa, S., Bakunina, K., Minnema, M. C., Seute, T., Durian, M., Cull, G., Schouten, H. C., Stevens, W. B. C., Zijlstra, J. M., Baars, J. W., Nijland, M., Mason, K. D., Beeker, A., van den Bent, M. J., Beijert, M., Gonzales, M., de Jong, D. & Doorduijn, J. K., 1 Feb 2019, In : The Lancet Oncology. 20, 2, p. 216-228 13 p.

Research output: Contribution to journalArticle

Lymphoma
Methotrexate
Rituximab
Teniposide
Drug Therapy
2 Citations (Scopus)

Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Barrientos, J. C., O'Brien, S., Brown, J. R., Kay, N. E., Reddy, N. M., Coutre, S., Tam, C., Mulligan, S., Jaeger, U., Devereux, S., Pocock, C., Robak, T., Schuster, S. J., Schuh, A., Gill, D., Bloor, A., Dearden, C., Moreno, C., Cull, G., Hamblin, M. & 8 othersJones, J. A., Eckert, K., Solman, I. G., Suzuki, S., Hsu, E., James, D. F., Byrd, J. C. & Hillmen, P., Dec 2018, In : Clinical Lymphoma, Myeloma & Leukemia. 18, 12, p. 803-+ 18 p.

Research output: Contribution to journalArticle

Open Access